Henry Schein (HSIC) Competitors $66.23 +0.74 (+1.13%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock HSIC vs. PDCO, OMI, MCK, COR, CAH, ALNY, HUM, CNC, A, and GEHCShould you be buying Henry Schein stock or one of its competitors? The main competitors of Henry Schein include Patterson Companies (PDCO), Owens & Minor (OMI), McKesson (MCK), Cencora (COR), Cardinal Health (CAH), Alnylam Pharmaceuticals (ALNY), Humana (HUM), Centene (CNC), Agilent Technologies (A), and GE HealthCare Technologies (GEHC). These companies are all part of the "medical" sector. Henry Schein vs. Patterson Companies Owens & Minor McKesson Cencora Cardinal Health Alnylam Pharmaceuticals Humana Centene Agilent Technologies GE HealthCare Technologies Henry Schein (NASDAQ:HSIC) and Patterson Companies (NASDAQ:PDCO) are both mid-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, dividends, analyst recommendations, profitability, valuation, risk, community ranking and media sentiment. Does the MarketBeat Community believe in HSIC or PDCO? Henry Schein received 18 more outperform votes than Patterson Companies when rated by MarketBeat users. Likewise, 51.63% of users gave Henry Schein an outperform vote while only 50.07% of users gave Patterson Companies an outperform vote. CompanyUnderperformOutperformHenry ScheinOutperform Votes38051.63% Underperform Votes35648.37% Patterson CompaniesOutperform Votes36250.07% Underperform Votes36149.93% Do institutionals and insiders believe in HSIC or PDCO? 96.6% of Henry Schein shares are held by institutional investors. Comparatively, 85.4% of Patterson Companies shares are held by institutional investors. 1.1% of Henry Schein shares are held by company insiders. Comparatively, 1.9% of Patterson Companies shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Is HSIC or PDCO more profitable? Henry Schein has a net margin of 2.51% compared to Patterson Companies' net margin of 2.37%. Patterson Companies' return on equity of 19.77% beat Henry Schein's return on equity.Company Net Margins Return on Equity Return on Assets Henry Schein2.51% 12.90% 5.21% Patterson Companies 2.37%19.77%6.66% Which has more volatility and risk, HSIC or PDCO? Henry Schein has a beta of 0.84, indicating that its stock price is 16% less volatile than the S&P 500. Comparatively, Patterson Companies has a beta of 0.73, indicating that its stock price is 27% less volatile than the S&P 500. Does the media prefer HSIC or PDCO? In the previous week, Henry Schein and Henry Schein both had 18 articles in the media. Henry Schein's average media sentiment score of 1.32 beat Patterson Companies' score of 1.12 indicating that Henry Schein is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Henry Schein 13 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Patterson Companies 15 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has preferable earnings and valuation, HSIC or PDCO? Henry Schein has higher revenue and earnings than Patterson Companies. Patterson Companies is trading at a lower price-to-earnings ratio than Henry Schein, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHenry Schein$12.67B0.63$416M$3.0421.55Patterson Companies$6.51B0.43$185.93M$1.5420.34 Do analysts rate HSIC or PDCO? Henry Schein presently has a consensus price target of $81.10, indicating a potential upside of 23.78%. Patterson Companies has a consensus price target of $26.57, indicating a potential downside of 15.19%. Given Henry Schein's stronger consensus rating and higher probable upside, equities research analysts plainly believe Henry Schein is more favorable than Patterson Companies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Henry Schein 0 Sell rating(s) 5 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.64Patterson Companies 0 Sell rating(s) 10 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.09 SummaryHenry Schein beats Patterson Companies on 15 of the 18 factors compared between the two stocks. Get Henry Schein News Delivered to You Automatically Sign up to receive the latest news and ratings for HSIC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HSIC vs. The Competition Export to ExcelMetricHenry ScheinMedical & hospital equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.03B$8.02B$5.35B$7.51BDividend YieldN/A1.99%5.44%4.33%P/E Ratio26.9621.2421.9618.05Price / Sales0.631.21391.99104.31Price / Cash11.6810.7638.2034.62Price / Book1.982.136.744.14Net Income$416M$259.21M$3.21B$247.59M7 Day Performance1.22%-0.20%4.00%3.51%1 Month Performance-7.41%-7.27%-7.00%-5.80%1 Year Performance-10.51%-12.54%15.59%2.83% Henry Schein Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HSICHenry Schein3.4454 of 5 stars$66.23+1.1%$81.10+22.5%-10.0%$8.11B$12.67B27.2622,000PDCOPatterson Companies3.3849 of 5 stars$31.33flat$26.57-15.2%N/A$2.77B$6.51B18.327,700News CoverageOMIOwens & Minor4.7589 of 5 stars$6.51-6.1%$12.50+92.0%-74.0%$502.93M$10.70B-10.0222,500MCKMcKesson4.6066 of 5 stars$682.82-2.0%$668.50-2.1%+30.2%$85.58B$344.58B31.2675,000Positive NewsCORCencora4.2401 of 5 stars$281.32-1.9%$284.55+1.1%+19.8%$54.55B$638.56M40.0242,000Upcoming EarningsInsider TradePositive NewsCAHCardinal Health4.6544 of 5 stars$131.32-2.5%$140.86+7.3%+30.0%$31.72B$222.28B24.5046,500Upcoming EarningsPositive NewsALNYAlnylam Pharmaceuticals4.5951 of 5 stars$232.75-0.8%$315.58+35.6%+65.7%$30.28B$2.25B-107.262,000Upcoming EarningsAnalyst UpgradePositive NewsHUMHumana3.4592 of 5 stars$246.07-7.0%$284.90+15.8%-19.6%$29.70B$117.76B24.7367,100Upcoming EarningsDividend AnnouncementCNCCentene4.9664 of 5 stars$57.97-4.5%$80.69+39.2%-18.1%$28.76B$163.07B9.2974,300Upcoming EarningsPositive NewsAAgilent Technologies4.7333 of 5 stars$100.29-2.1%$143.00+42.6%-24.5%$28.59B$6.51B23.0617,900Analyst ForecastGEHCGE HealthCare Technologies4.6847 of 5 stars$60.48-3.0%$97.27+60.8%-24.7%$27.69B$19.67B13.9750,000Upcoming EarningsAnalyst ForecastOptions VolumeNews CoveragePositive News Related Companies and Tools Related Companies PDCO Competitors OMI Competitors MCK Competitors COR Competitors CAH Competitors ALNY Competitors HUM Competitors CNC Competitors A Competitors GEHC Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HSIC) was last updated on 4/24/2025 by MarketBeat.com Staff From Our PartnersTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThe Exact July Date the AI Correction Will End?AI stocks have cooled off—but Jeff Brown, the tech expert who picked Nvidia before it soared 222x, says one da...Brownstone Research | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredVirtually Limitless Energy?A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discov...Stansberry Research | SponsoredTrump’s treachery Intuitive Surgical at $1.99. Nvidia at $11. Shorting Fannie Mae months before collapse. That’s this analyst’s ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Henry Schein, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Henry Schein With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.